A growing number of patients are requesting unvaccinated blood for transfusions, a trend that can delay treatment and complicate care.

There is no evidence that unvaccinated blood provides any safety advantage, according to a new study published in the journal Transfusion.

"There is no evidence that unvaccinated blood presents any safety benefit," the authors state, challenging assumptions about donor status and risk.

The Vanderbilt study situates this trend within a real clinical setting. It tracked 15 requests for unvaccinated blood between January 1, 2024, and December 31, 2025.

Here's What They're Not Telling You About Your Retirement

The median age of patients was 17, and more than half were children, underscoring that concerns about vaccination status can affect younger patients and complicate standard transfusion protocols.

A substantial portion of the requests involved direct donations from family members. Thirteen of the patients received blood donated specifically for them by relatives, a practice known as direct donation.

This approach can be risky because most direct donors are first-time donors, and their donations are more likely to contain potentially harmful pathogens, the study notes. "Despite being framed as ‘safer,’ directed donations may paradoxically increase risk."

A different clinical reality emerged for some patients. Among the studied patient group, two became much sicker after refusing a standard blood transfusion.

This Could Be the Most Important Video Gun Owners Watch All Year

One developed anemia, and the other experienced hemodynamic shock, a serious condition marked by insufficient blood flow and oxygen delivery to tissues. These cases illustrate how doubts about source materials can have real clinical repercussions.

The phenomenon grew in the wake of COVID-19 vaccine approvals, with requests for unvaccinated blood spiking and posing a recurring challenge for transfusion services and clinicians, the researchers observed. Hospitals must balance patient desires with safety data and supply realities, all while maintaining other patients’ access to timely care in an already pressured system.

The researchers emphasize that such requests can lead to care delays, escalation of care, and inefficiencies. When teams must search for compatible units or navigate ethical considerations, patient flow can slow, and patients may experience longer waits for potentially life-saving treatment. The operational toll is a real concern for busy transfusion services.

Several health policy voices have called for standardized policies to handle these requests, arguing for consistency across institutions.

Regulatory and professional organizations have opposed these non-evidence-based policies, emphasizing that blood centers do not record or convey donor COVID-19 vaccination status and that evidence demonstrates transfusion from vaccinated donors poses no unique risk.

The Vanderbilt report also notes several limitations. It examined a small number of cases and included only those instances where special blood donations reached the blood bank, so it does not reveal how common these requests are overall. The study did not account for cases resolved through conversations with doctors or ethics teams, limiting the breadth of its conclusions.

In the policy arena, several states have floated proposals to permit transfusion of blood from unvaccinated donors. In one example, Oklahoma considered a state-run blood bank dedicated to collecting and distributing blood from unvaccinated donors. Despite such efforts, none of the measures has become law, leaving a patchwork of ideas without formal adoption.

Voice from the medical community adds another dimension. Dr. Marc Siegel, a senior medical analyst, described these requests as part of an ongoing fear culture.

"It is also very difficult to test for, because the antibodies may be positive from COVID itself as well as the vaccine, and it can be difficult to tell the difference," he explained to readers. "The notion that receiving blood from someone who had the vaccine would be harmful is not based on any scientific studies, the doctor reiterated." If people want to group up to get blood from other unvaccinated people, I respect that choice, though it will be expensive and will limit options, he added.

Industry representatives who oversee blood centers acknowledge the rarity of these requests. Diane Calmus, vice president of government affairs for America’s Blood Centers, noted that requests for unvaccinated blood are exceedingly rare, representing about 0.06% of the U.S. blood supply.

"Requests for unvaccinated blood are something we've seen wax and wane since the introduction of the COVID vaccine," she said, adding that there is no test to determine vaccination status. "The challenge is that there's no way to tell whether someone’s blood has been vaccinated – there's no test that exists."

Health professionals stress that dignity and safety must guide every transfusion decision. Blood has to be prescribed. You can't just show up at the blood center and say, "I would like my sister to donate for me," she explained.

There needs to be a prescription, and it must go through the hospital to ensure it is the right blood for the right patient. The U.S. blood supply is meticulously tracked, and there have been no indications of a safety problem tied to donors' vaccination status.

In the end, health leaders urge action rooted in science and compassion.

They remind communities that the best defense is robust blood donation from all willing donors, regardless of vaccination status.

We need people – vaccinated or not vaccinated – to show up and donate blood, because it is the blood on the shelves that saves lives.